Basel Medical Group Ltd (BMGL)

Profile

Full Name

Basel Medical Group Ltd Ordinary Shares

Ticker Symbol

BMGL

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

Singapore

IPO

Indexes

Not included

Website

http://baselmedical.com

Employees

32

Key Details

Price

$4.50(-4.36%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.45M(+4.78% YoY)

Annual EPS

$0.08(+17.49% YoY)

PE ratio

-

Next earnings date

Apr 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.50
BMGL price is $4.50

30-Day Relative Volume

1.83
BMGL 30-day relative volume is 1.83

Price Performance

Price Most recent change

-4.36%
BMGL price was down -4.36% on Apr 11, 2025

Price YTD change

-
BMGL price ytd change is unknown

Price 1-year change

-
BMGL price 1-year change is unknown

Price 3-year change

-
BMGL price 3-year change is unknown

Price Range

Price All-time high

$5.50
BMGL price is currently -18.18% below its historical high of $5.50

Price 3-year low

$3.63
BMGL price is currently +23.97% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$83.05M
BMGL market capitalization is $83.05 million

Market cap 3-year change

-
BMGL market capitalization 3-year change is unknown

Market cap All-time high

$101.32M
BMGL market capitalization is currently -18.03% below its historical high of $101.32 million

Market cap sector rank

46.51%
BMGL market capitalization is higher than 46.51% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
BMGL shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
BMGL shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.65
BMGL beta is 0.65

200-day SMA

$4.38
BMGL price is currently +2.73% above its 200-day simple moving average

50-day SMA

$4.38
BMGL price is currently +2.73% above its 50-day simple moving average

RSI

48.80
BMGL 14-day relative strength index is 48.80

Volume

1.83
BMGL 30-day relative volume is 1.83

ATR

$0.58
BMGL average true range is $0.58

10-day Historical Volatility

145.38%
BMGL 10-day historical volatility is 145.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.45M
BMGL annual revenue is $7.45 million

Revenue Analysts estimate

-
BMGL annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+4.78%
BMGL annual revenue is up +4.78% year-on-year

Revenue Sector rank

-
BMGL annual revenue is unknown

EPS

EPS

$0.08
BMGL annual earnings per share is $0.08

EPS Analysts estimate

-
BMGL annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+17.49%
BMGL annual earnings per share is up +17.49% year-on-year

EPS Sector rank

-
BMGL annual earnings per share is unknown

Profit

Gross profit

$5.79M
BMGL annual gross profit is $5.79 million

Gross margin

77.63%
BMGL annual gross profit margin is 77.63%

Operating profit

$1.91M
BMGL annual operating income is $1.91 million

Operating margin

25.68%
BMGL annual operating profit margin is 25.68%

Net income

$1.54M
BMGL annual net profit is $1.54 million

Net margin

20.62%
BMGL annual net profit margin is 20.62%

Expenses

Total expenses

$5.54M
BMGL annual total expenses is $5.54 million

Operating expenses

$3.87M
BMGL annual total operating expenses is $3.87 million

Cost of goods sold

$1.67M
BMGL annual cost of goods sold is $1.67 million

Selling, general & administrative expenses

$2.70M
BMGL annual SGA is $2.70 million

Depreciation and amortization

$392.10K
BMGL annual depreciation & amortization is $392.10 thousand

Interest expense

$130.70K
BMGL annual interest expense is $130.70 thousand

Income tax

$246.10K
BMGL annual income tax is $246.10 thousand

EBIT & EBITDA

EBIT

$1.91M
BMGL annual earnings before interest & taxes is $1.91 million

EBITDA

$2.31M
BMGL annual EBITDA is $2.31 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.02M
BMGL annual total assets is $12.02 million

Non current assets

$99.50K
BMGL annual long term assets is $99.50 thousand

Current assets

$11.92M
BMGL annual total current assets is $11.92 million

Cash and cash equivalents

$1.44M
BMGL annual cash & cash equivalents is $1.44 million

Accounts receivable

$1.23M
BMGL annual accounts receivable is $1.23 million

Inventory

$53.10K
BMGL annual inventory is $53.10 thousand

Liabilities

Total liabilities

$6.45M
BMGL annual total liabilities is $6.45 million

Long term liabilities

$1.17M
BMGL annual total long term liabilities is $1.17 million

Current liabilities

$5.28M
BMGL annual total current liabilities is $5.28 million

Accounts payable

$611.10K
BMGL annual accounts payable is $611.10 thousand

Debt

Total debt

$3.16M
BMGL annual total debt is $3.16 million

Total debt 1-year change

-40.56%
BMGL annual total debt is down -40.56% year-on-year

Long term debt

$1.17M
BMGL annual long term debt is $1.17 million

Short term debt

$1.99M
BMGL annual short term debt is $1.99 million

Equity & Capital

Shareholders equity

$5.57M
BMGL annual stockholders equity is $5.57 million

Book value

$5.57M
BMGL annual book value is $5.57 million

Retained earnings

$5.57M
BMGL annual retained earnings is $5.57 million

Working capital

$6.64M
BMGL annual working capital is $6.64 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.86M
BMGL annual cash flow from operations is $1.86 million

Cash from operations 1-year change

-2.39%
BMGL annual cash flow from operations is down -2.39% year-on-year

Cash from investing

-$5900.00
BMGL annual cash flow from investing activities is -$5900.00

Cash from investing 1-year change

-31.11%
BMGL annual cash flow from investing activities is down -31.11% year-on-year

Cash from financing

-$1.31M
BMGL annual cash flow from financing activities is -$1.31 million

Cash from financing 1-year change

+39.19%
BMGL annual cash flow from financing activities is up +39.19% year-on-year

CAPEX

CAPEX

$5900.00
BMGL annual capital expenditures is $5900.00

CAPEX 1-year change

+31.11%
BMGL annual capital expenditures is up +31.11% year-on-year

Free Cash Flow

Free cash flow

$1.86M
BMGL annual free cash flow is $1.86 million

Free cash flow 1-year change

-2.47%
BMGL annual free cash flow is down -2.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

77.63%
BMGL annual gross profit margin is 77.63%

Operating margin

25.68%
BMGL annual operating profit margin is 25.68%

Net margin

20.62%
BMGL annual net profit margin is 20.62%

ROA & ROE

ROA

13.16%
BMGL annual return on assets is 13.16%

ROE

31.96%
BMGL annual return on equity is 31.96%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BMGL price to earnings ratio value is unknown

PE ratio Sector rank

-
BMGL price to earnings ratio is unknown

PB Ratio

PB ratio

14.90
BMGL price to book ratio is 14.90

PB ratio Sector rank

95.97%
BMGL price to book ratio is higher than 95.97% of companies in Healthcare sector

PS Ratio

PS ratio

-
BMGL price to sales ratio value is unknown

PS ratio Sector rank

-
BMGL price to sales ratio is unknown

Enterprise value

Enterprise value

$84.77M
BMGL enterprise value is $84.77 million

Enterprise value Sector rank

48.47%
BMGL enterprise value is higher than 48.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
BMGL EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
BMGL EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.26
BMGL annual current ratio is 2.26

Quick ratio

2.25
BMGL annual quick ratio is 2.25

Leverage

Debt to equity

0.56
BMGL annual debt to equity ratio is 0.56

Interest coverage ratio

14.64
BMGL annual interest coverage ratio is 14.64

Risk & Stability

Piotroski F-Score

-
BMGL piotroski f-score value is unknown

Altman Z-Score

10.19
BMGL altman z-score is 10.19

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

ANIX logo
Anixa Biosciences (ANIX)
Zura Bio Limited (ZURA)
HLVX logo
HilleVax (HLVX)
ATOS logo
Atossa Therapeutics (ATOS)
VXRT logo
Vaxart (VXRT)
PLRX logo
Pliant Therapeutics (PLRX)
MGNX logo
MacroGenics (MGNX)
SNTI logo
Senti Biosciences (SNTI)
CRBU logo
Caribou Biosciences (CRBU)
  • What is the ticker symbol for Basel Medical Group Ltd?
  • Does Basel Medical Group Ltd pay dividends?
  • What sector is Basel Medical Group Ltd in?
  • What industry is Basel Medical Group Ltd in?
  • What country is Basel Medical Group Ltd based in?
  • Is Basel Medical Group Ltd in the S&P 500?
  • Is Basel Medical Group Ltd in the NASDAQ 100?
  • Is Basel Medical Group Ltd in the Dow Jones?
  • When was Basel Medical Group Ltd's last earnings report?
  • When does Basel Medical Group Ltd report earnings?

What is the ticker symbol for Basel Medical Group Ltd?

The ticker symbol for Basel Medical Group Ltd is NASDAQ:BMGL

Does Basel Medical Group Ltd pay dividends?

No, Basel Medical Group Ltd does not pay dividends

What sector is Basel Medical Group Ltd in?

Basel Medical Group Ltd is in the Healthcare sector

What industry is Basel Medical Group Ltd in?

Basel Medical Group Ltd is in the Medical Care Facilities industry

What country is Basel Medical Group Ltd based in?

Basel Medical Group Ltd is headquartered in Singapore

Is Basel Medical Group Ltd in the S&P 500?

No, Basel Medical Group Ltd is not included in the S&P 500 index

Is Basel Medical Group Ltd in the NASDAQ 100?

No, Basel Medical Group Ltd is not included in the NASDAQ 100 index

Is Basel Medical Group Ltd in the Dow Jones?

No, Basel Medical Group Ltd is not included in the Dow Jones index

When was Basel Medical Group Ltd's last earnings report?

Basel Medical Group Ltd's most recent earnings report was on Apr 8, 2025

When does Basel Medical Group Ltd report earnings?

The next expected earnings date for Basel Medical Group Ltd is Apr 15, 2025
On this page